Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -99.7MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 4.24Close
$ 1.71 - $ 9.29 52-Week Range
Ticker Information
Ticker
LRMRCompany Name
LARIMAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLARIMAR THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LRMR - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 90K | $ -99.79M | $ -99.7M |
| 3/31/2025 | $ 120K | $ -95.23M | $ -95.11M |
| 12/31/2024 | $ 129K | $ -80.6M | $ -80.47M |
| 9/30/2024 | $ 166K | $ -64.77M | $ -64.61M |
| 6/30/2024 | $ 207K | $ -58.34M | $ -58.13M |
| 3/31/2024 | $ 212K | $ -45.08M | $ -44.87M |
| 12/31/2023 | $ 229K | $ -36.95M | $ -36.72M |
| 9/30/2023 | $ 204K | $ -33.38M | $ -33.18M |
| 6/30/2023 | $ 212K | $ -32.64M | $ -32.42M |
| 3/31/2023 | $ 244K | $ -32.94M | $ -32.69M |
Key Performance Insights, Last 5 Years
- LARIMAR THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -31.61M.
- Over the past 5 years, LARIMAR THERAPEUTICS INC's average EBITDA has been $ -50.72M.
- The median EBITDA for LARIMAR THERAPEUTICS INC during this period was $ -46.01M
- LARIMAR THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -31.61M.
- The lowest EBITDA recorded by LARIMAR THERAPEUTICS INC in the same timeframe $ -99.7M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for LARIMAR THERAPEUTICS INC is calculated as follows: EBIT [ $ -31.79M ] + DepAmor [ $ 183K ]
(=) EBITDA [ $ -31.61M ] LRMR - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -99.7M
Minimum
Jun 30, 2025
$ -31.61M
Maximum
Sep 30, 2020
$ -50.72M
Average
$ -46.01M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.77M with a standard deviation of $ 166.95M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.77M |
| median | $ 8.83M |
| std | $ 166.95M |